Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články
PubMed
36635857
PubMed Central
PMC10062349
DOI
10.1093/europace/euac267
PII: 6986483
Knihovny.cz E-zdroje
- Klíčová slova
- Arrhythmogenic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, ECG, Site of origin, Ventricular arrhythmia,
- MeSH
- blokáda Tawarova raménka MeSH
- elektrokardiografie MeSH
- kardiomyopatie * komplikace diagnóza MeSH
- komorová tachykardie * etiologie komplikace MeSH
- lidé MeSH
- srdeční komory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: Little is known about patients with right bundle branch block (RBBB)-ventricular tachycardia (VT) and arrhythmogenic cardiomyopathy (ACM). Our aims were: (i) to describe electrocardiogram (ECG) characteristics of sinus rhythm (SR) and VT; (ii) to correlate SR with RBBB-VT ECGs; and (iii) to compare VT ECGs with electro-anatomic mapping (EAM) data. METHODS AND RESULTS: From the European Survey on ACM, 70 patients with spontaneous RBBB-VT were included. Putative left ventricular (LV) sites of origin (SOOs) were estimated with a VT-axis-derived methodology and confirmed by EAM data when available. Overall, 49 (70%) patients met definite Task Force Criteria. Low QRS voltage predominated in lateral leads (n = 37, 55%), but QRS fragmentation was more frequent in inferior leads (n = 15, 23%). T-wave inversion (TWI) was equally frequent in inferior (n = 28, 42%) and lateral (n = 27, 40%) leads. TWI in inferior leads was associated with reduced LV ejection fraction (LVEF; 46 ± 10 vs. 53 ± 8, P = 0.02). Regarding SOOs, the inferior wall harboured 31 (46%) SOOs, followed by the lateral wall (n = 17, 25%), the anterior wall (n = 15, 22%), and the septum (n = 4, 6%). EAM data were available for 16 patients and showed good concordance with the putative SOOs. In all patients with superior-axis RBBB-VT who underwent endo-epicardial VT activation mapping, VT originated from the LV. CONCLUSIONS: In patients with ACM and RBBB-VT, RBBB-VTs originated mainly from the inferior and lateral LV walls. SR depolarization and repolarization abnormalities were frequent and associated with underlying variants.
Cardiology Department Hospital Universitario Virgen de las Nieves Granada Spain
Center for Biomedical Network Research on Cardiovascular Diseases Madrid Spain
Centre Hospitalier Universitaire d'Amiens Picardie Amiens France
Department of Cardiology Erasme University Hospital Université Libre de Bruxelles Brussels Belgium
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic
Department of Cardiology University Heart Center Zurich Zurich Switzerland
Department of Cardiology University Medical Center Utrecht The Netherlands
Department of Genetics University Medical Center Utrecht The Netherlands
Division of Cardiology Policlinico Casilino Roma Italy
Hôpital Cardiologique du Haut Lévêque and Université Bordeaux LIRYC Institute Bordeaux France
IRCCS San Raffaele Scientific Institute Milan Italy
Netherlands Heart Institute Utrecht The Netherlands
Service de Cardiologie CHU de Nantes Nantes France
Université de Lille et Institut Cœur Poumon CHRU Lille Lille France
Zobrazit více v PubMed
Gandjbakhch E, Redheuil A, Pousset F, Charron P, Frank R. Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Am Coll Cardiol 2018;72:784–804. PubMed
Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCCet al. . 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary. Heart Rhythm 2019;16:e373–407. PubMed
Belhassen B, Shmilovich H, Nof E, Milman A. A case report of arrhythmogenic ventricular cardiomyopathy presenting with sustained ventricular tachycardia arising from the right and the left ventricles before structural changes are documented. Eur Heart J Case Rep 2020;4:1–7. PubMed PMC
Belhassen B, Laredo M, Roudijk RW, Peretto G, Zahavi G, Sen-Chowdhry Set al. . The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy. Europace 2022;24:285–95. PubMed
Marchlinski DF, Tschabrunn CM, Zado ES, Santangeli P, Marchlinski FE. Right bundle branch block ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy more commonly originates from the right ventricle: criteria for identifying chamber of origin. Heart Rhythm 2021;18:163–71. PubMed
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DAet al. . Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J 2010;31:806–14. PubMed PMC
Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, Lazzari MDet al. . Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. Int J Cardiol 2020;319:106–14. PubMed
Peters S, Trümmel M, Koehler B. QRS Fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia–cardiomyopathy. Heart Rhythm 2008;5:1417–21. PubMed
Tschabrunn CM, Haqqani HM, Santangeli P, Zado ES, Marchlinski FE. 12-Lead Electrocardiogram to localize region of abnormal electroanatomic substrate in arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol 2017;3:654–65. PubMed
Andreu D, Fernández-Armenta J, Acosta J, Penela D, Jáuregui B, Soto-Iglesias Det al. . A QRS axis–based algorithm to identify the origin of scar-related ventricular tachycardia in the 17-segment American heart association model. Heart Rhythm 2018;15:1491–7. PubMed
Casella M, Gasperetti A, Sicuso R, Conte E, Catto V, Sommariva Eet al. . Characteristics of patients with arrhythmogenic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2020;13:e009005. PubMed
Corrado D, van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, Asimaki Aet al. . Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J 2020;41:1414–29. PubMed PMC
Corrado D, Marra MP, De Lazzari M, Cipriani A, Zorzi A. Diagnosis and prognosis of arrhythmogenic left ventricular cardiomyopathy. J Am Coll Cardiol 2020;76:1387–8. PubMed
Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta ACet al. . Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation 2020;141:1872–84. PubMed PMC
Cipriani A, Bauce B, De Lazzari M, Rigato I, Bariani R, Meneghin Set al. . Arrhythmogenic right ventricular cardiomyopathy: characterization of left ventricular phenotype and differential diagnosis with dilated cardiomyopathy. J Am Heart Assoc 2020;9:e014628. PubMed PMC
Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward Det al. . Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008;52:2175–87. PubMed
De Lazzari M, Zorzi A, Cipriani A, Susana A, Mastella G, Rizzo Aet al. . Relationship between electrocardiographic findings and cardiac magnetic resonance phenotypes in arrhythmogenic cardiomyopathy. J Am Heart Assoc 2018;7:e009855. PubMed PMC
Zorzi A, Perazzolo Marra M, Rigato I, De Lazzari M, Susana A, Niero Aet al. . Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circ Arrhythm Electrophysiol 2016;9:e004229. PubMed PMC
van Rijsingen IAW, van der Zwaag PA, Groeneweg JA, Nannenberg EA, Jongbloed JDH, Zwinderman AHet al. . Outcome in phospholamban R14del carriers: results of a large multicentre cohort study. Circ Cardiovasc Genet 2014;7:455–65. PubMed
Oloriz T, Wellens HJJ, Santagostino G, Trevisi N, Silberbauer J, Peretto Get al. . The value of the 12-lead electrocardiogram in localizing the scar in non-ischaemic cardiomyopathy. Europace 2016;18:1850–9. PubMed